Search Results - "Strik, Herwig M."

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    Glycobiology in malignant gliomas: expression and functions of galectins and possible therapeutic options by Strik, Herwig M, Kolodziej, Malgorzata, Oertel, Wolfgang, Basecke, Jorg

    Published in Current pharmaceutical biotechnology (01-09-2012)
    “…Malignant gliomas, the most common malignant primary brain tumors, have a deleterious clinical prognosis of approximately 12 months in unselected series. The…”
    Get more information
    Journal Article
  2. 2

    Chloroethylating nitrosoureas in cancer therapy: DNA damage, repair and cell death signaling by Nikolova, Teodora, Roos, Wynand P., Krämer, Oliver H., Strik, Herwig M., Kaina, Bernd

    “…Chloroethylating nitrosoureas (CNU), such as lomustine, nimustine, semustine, carmustine and fotemustine are used for the treatment of malignant gliomas, brain…”
    Get full text
    Journal Article
  3. 3

    Immune Cell Infiltration of Intrinsic and Metastatic Intracranial Tumours by STRIK, Herwig M, STOLL, Manuel, MEYERMANN, Richard

    Published in Anticancer research (01-01-2004)
    “…Background: Immune escape is one prerequisite for the formation of neoplasms that is reflected by the pattern of immune cell infiltration. Abundant monocytic…”
    Get full text
    Journal Article
  4. 4

    Temozolomide Dosing Regimens for Glioma Patients by Strik, Herwig M., Marosi, Christine, Kaina, Bernd, Neyns, Bart

    Published in Current neurology and neuroscience reports (01-06-2012)
    “…Even in modern times of high-precision brain surgery and irradiation, malignant gliomas belong to the deadliest types of cancer. Due to a marked primary and…”
    Get full text
    Journal Article
  5. 5

    Models of Monocytic Invasion into Glioma Cell Aggregates by STRIK, Herwig M, HÜLPER, Petra, ERDLENBRUCH, Bernhard, MEIER, Jessica, KOWALEWSKI, Alexandra, HEMMERLEIN, Bernhard, GOLD, Ralf, BÄHR, Mathias

    Published in Anticancer research (01-03-2006)
    “…Background: In order to investigate why human gliomas are abundantly infiltrated by monocytic cells without signs of antitumor activity, experimental models…”
    Get full text
    Journal Article
  6. 6

    Clinical Response Following Adjuvant Temozolomide in a Patient with Primary Cerebral Lymphoma by STRIK, Herwig M, SPREER, Annette, NAGEL, Holger, JACOB, Sonja, JUNG, Wolfram, KITZE, Bernd, BÄHR, Mathias

    Published in Anticancer research (01-11-2004)
    “…A 69-year-old female patient was treated for primary CNS-lymphoma (PCNSL) starting from August 2002. As her general condition allowed no high-dose methotrexate…”
    Get full text
    Journal Article
  7. 7

    Cerebrospinal fluid ferritin--unspecific and unsuitable for disease monitoring by Kolodziej, Malgorzata A, Proemmel, Peter, Quint, Karl, Strik, Herwig M

    Published in Neurologia i neurochirurgia polska (01-01-2014)
    “…Subarachnoid hemorrhage is sometimes difficult to diagnose radiologically. Cerebrospinal fluid (CSF) ferritin has been proposed to be highly specific and…”
    Get more information
    Journal Article
  8. 8
  9. 9

    Galectin-1 expression in human glioma cells : Modulation by ionizing radiation and effects on tumor cell proliferation and migration by STRIK, Herwig M, SCHMIDT, Katharina, LINGOR, Paul, TÖNGES, Lars, KUGLER, Wilfried, NITSCHE, Mirko, RABINOVICH, Gabriel A, BÄHR, Mathias

    Published in Oncology reports (01-08-2007)
    “…Galectins are evolutionarily conserved beta-galactoside-binding lectins which recognize specific glycoconjugates on the cell surface and the extracellular…”
    Get full text
    Journal Article
  10. 10

    Localization of endostatin in rat and human gliomas by Strik, Herwig M., Schluesener, Hermann J., Seid, Karin, Meyermann, Richard, Deininger, Martin H.

    Published in Cancer (01-03-2001)
    “…BACKGROUND Endostatin is a potent inhibitor of endothelial cell proliferation, angiogenesis, and tumor growth. Its occurrence and localization has not yet been…”
    Get full text
    Journal Article
  11. 11

    Galectin-3: cellular distribution and correlation with WHO-grade in human gliomas by STRIK, Herwig M, DEININGER, Martin H, FRANK, Brigitte, SCHLUESENER, Herrmann J, MEYERMANN, Richard

    Published in Journal of neuro-oncology (01-05-2001)
    “…In order to elucidate the reason for conflicting results that have been published previously on galectin-3 expression in human gliomas, we used single labeling…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Rechallenge with temozolomide with different scheduling is effective in recurrent malignant gliomas by Strik, H M, Buhk, J-H, Wrede, A, Hoffmann, A L, Bock, H C, Christmann, M, Kaina, B

    Published in Molecular medicine reports (01-11-2008)
    “…Treatment of recurrent malignant glioma, which has a poor patient prognosis, has not been standardised. Moreover, it is unclear whether repeated treatment with…”
    Get full text
    Journal Article
  14. 14

    Three-dimensional reconstruction and volumetry of intracranial haemorrhage and its mass effect by STRIK, H. M, BORCHERT, H, FELS, C, KNAUTH, M, RIENHOFF, O, BÄHR, M, VERHEY, J. F

    Published in Neuroradiology (01-06-2005)
    “…Intracerebral haemorrhage still causes considerable disability and mortality. The studies on conservative and operative management are inconclusive, probably…”
    Get full text
    Journal Article
  15. 15
  16. 16

    The impact of progesterone receptor expression on relapse in the long-term clinical course of 93 benign meningiomas by Strik, H M, Strobelt, I, Pietsch-Breitfeld, B, Iglesias-Rozas, J R, Will, B, Meyermann, Richard

    Published in In vivo (Athens) (01-07-2002)
    “…Previous clinicopathological observations have pointed towards an impact of progesterone receptor (PgR) expression on the clinical course of meningiomas…”
    Get more information
    Journal Article